Details for 2017160386
Up to date per 04.04.2026
Actions
Details for 2017160386
Granted/Registered
European Patent
25.10.2017 A
04.09.2019 B1
18.05.2011
US
201161487497 P
C07D 215/56 20060101AFI20170714BHEP
Owner
Vertex Pharmaceuticals (Europe) Limited2 Kingdom Street London W2 6BDGB
Representative
Representative
Haffner & Keschmann Patentanwälte GmbHSchottengasse 3a1010 WienAT
Inventor
Morgan,, Adam J14 Oak Ridge Lane Ashland, MA Massachusetts 01721US
Information about Fees